Statins are among the most commonly prescribed medicines in the world, yet they are also some of the most misunderstood.
Many people worry that statins can cause memory loss, depression, sleep problems, sexual difficulties, or other serious side effects. These fears often come from warning leaflets inside medicine packages or stories shared online.
However, a major new study led by researchers at Oxford Population Health and published on Lancet has found strong evidence that most of these concerns are not supported by reliable scientific data.
Heart and blood vessel disease remains one of the biggest health threats worldwide. It causes around 20 million deaths every year and accounts for about one in four deaths in the United Kingdom. High levels of LDL cholesterol, often called “bad” cholesterol, play a key role in blocking blood vessels and raising the risk of heart attacks and strokes.
Statins lower LDL cholesterol and have been shown again and again to save lives by reducing these risks. Despite this, many people who could benefit from statins choose not to take them because they are afraid of side effects.
To address these concerns, the research team carried out the most detailed and reliable review of statin side effects to date. They gathered data from 23 large, carefully designed clinical trials that included more than 150,000 participants in total.
Some of these trials compared people taking statins with people taking a placebo, which is a dummy pill. Others compared higher-dose statin treatment with lower-dose treatment. All of the trials followed participants for several years, with an average follow-up time of nearly five years.
Because these studies were randomized and double-blinded, neither the participants nor the doctors knew who was taking statins and who was not. This type of study design is considered the gold standard in medical research because it greatly reduces bias and allows researchers to see whether a drug truly causes certain effects.
The results were very clear. For almost all of the conditions listed in statin package leaflets, the number of people reporting problems was nearly the same in the statin group and the placebo group. For example, reports of memory or thinking problems occurred at a rate of about 0.2% per year in both groups.
This means that although some people taking statins experienced memory issues, the same number of people not taking statins reported the same problems. In other words, there was no solid evidence that statins were the cause.
The same pattern was seen for many other commonly feared side effects, including depression, poor sleep, erectile or sexual problems, weight gain, tiredness, headaches, and stomach discomfort. Taking a statin did not meaningfully increase the risk of these conditions compared with taking no statin at all.
The study did find a very small increase in abnormal liver blood test results among people taking statins, affecting about one extra person out of every thousand. However, there was no increase in serious liver disease, such as hepatitis or liver failure. This suggests that these blood test changes are usually mild and do not lead to real liver damage.
Earlier research by the same team has also shown that muscle pain, another common concern, is rarely caused by statins. Only about 1% of people experienced muscle symptoms related to statins in the first year of use, with no added risk after that.
Statins can slightly raise blood sugar levels, which means some people who are already at high risk may develop diabetes a little earlier. Even so, the heart-protecting benefits of statins greatly outweigh this small risk for most patients.
The researchers and independent experts agree that fear of side effects has led many people to avoid or stop statin treatment unnecessarily. This can result in preventable heart attacks, strokes, disability, and early death. The findings of this study strongly suggest that most side effects listed on statin labels are not actually caused by the drugs themselves.
After reviewing all the evidence, the study concludes that statins are far safer than many people believe. The benefits of lowering cholesterol and preventing serious heart problems clearly outweigh the small and limited risks for the vast majority of patients.
The researchers also argue that statin information leaflets should be updated to reflect the best available evidence, helping both doctors and patients make better decisions based on facts rather than fear.
If you care about heart health, please read studies that yogurt may help lower the death risks in heart disease, and coconut sugar could help reduce artery stiffness.
For more information about health, please see recent studies that Vitamin D deficiency can increase heart disease risk, and results showing vitamin B6 linked to lower death risk in heart disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
